首页> 外文期刊>Critical care : >Early non-invasive cardiac output monitoring in hemodynamically unstable intensive care patients: A multi-center randomized controlled trial
【24h】

Early non-invasive cardiac output monitoring in hemodynamically unstable intensive care patients: A multi-center randomized controlled trial

机译:血液动力学不稳定重症监护患者的早期无创心输出量监测:一项多中心随机对照试验

获取原文
           

摘要

IntroductionAcute hemodynamic instability increases morbidity and mortality. We investigated whether early non-invasive cardiac output monitoring enhances hemodynamic stabilization and improves outcome.MethodsA multicenter, randomized controlled trial was conducted in three European university hospital intensive care units in 2006 and 2007. A total of 388 hemodynamically unstable patients identified during their first six hours in the intensive care unit (ICU) were randomized to receive either non-invasive cardiac output monitoring for 24 hrs (minimally invasive cardiac output/MICO group; n = 201) or usual care (control group; n = 187). The main outcome measure was the proportion of patients achieving hemodynamic stability within six hours of starting the study.ResultsThe number of hemodynamic instability criteria at baseline (MICO group mean 2.0 (SD 1.0), control group 1.8 (1.0); P = .06) and severity of illness (SAPS II score; MICO group 48 (18), control group 48 (15); P = .86)) were similar. At 6 hrs, 45 patients (22%) in the MICO group and 52 patients (28%) in the control group were hemodynamically stable (mean difference 5%; 95% confidence interval of the difference -3 to 14%; P = .24). Hemodynamic support with fluids and vasoactive drugs, and pulmonary artery catheter use (MICO group: 19%, control group: 26%; P = .11) were similar in the two groups. The median length of ICU stay was 2.0 (interquartile range 1.2 to 4.6) days in the MICO group and 2.5 (1.1 to 5.0) days in the control group (P = .38). The hospital mortality was 26% in the MICO group and 21% in the control group (P = .34).ConclusionsMinimally-invasive cardiac output monitoring added to usual care does not facilitate early hemodynamic stabilization in the ICU, nor does it alter the hemodynamic support or outcome. Our results emphasize the need to evaluate technologies used to measure stroke volume and cardiac output--especially their impact on the process of care--before any large-scale outcome studies are attempted.Trial RegistrationThe study was registered at ClinicalTrials.gov (Clinical Trials identifier NCT00354211)
机译:简介急性血液动力学不稳定性会增加发病率和死亡率。我们调查了早期无创心输出量监测是否能增强血液动力学稳定性并改善结局。方法2006年和2007年,在欧洲三所大学医院的重症监护室进行了一项多中心,随机对照试验。在前6名患者中共发现388名血液动力学不稳定的患者重症监护病房(ICU)中的24小时随机分配接受24小时无创心输出量监测(微创心输出量/ MICO组; n = 201)或常规护理(对照组; n = 187)。主要结局指标是在研究开始后的六小时内达到血液动力学稳定性的患者比例。结果基线时的血液动力学不稳定标准数量(MICO组平均值2.0(SD 1.0),对照组1.8(1.0); P = .06)疾病的严重程度(SAPS II评分; MICO组48(18),对照组48(15); P = 0.86))相似。在6小时时,MICO组的45位患者(22%)和对照组的52位患者(28%)血流动力学稳定(平均差异5%;差异的95%置信区间-3至14%; P =)。 24)。两组的液体和血管活性药物的血流动力学支持以及肺动脉导管的使用(MICO组:19%,对照组:26%; P = .11)相似。 MICO组的ICU停留中位时间为2.0天(四分位数范围为1.2至4.6),对照组为2.5(1.1至5.0)天(P = 0.38)。 MICO组的住院死亡率为26%,对照组为21%(P = 0.34)。结论在常规护理中增加微创心输出量监测并不能促进ICU的早期血流动力学稳定,也不会改变血流动力学支持或结果。我们的结果强调,在尝试进行任何大规模结果研究之前,需要评估用于测量卒中量和心输出量(特别是其对护理过程的影响)的技术。试验注册该研究已在ClinicalTrials.gov(Clinical Trials)上注册标识符NCT00354211)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号